Advertisement

Irish Journal of Medical Science

, Volume 180, Issue 3, pp 703–707 | Cite as

The effects of ozone therapy and coenzyme Q10 combination on oxidative stress markers in healthy subjects

  • M. İnal
  • A. Dokumacioglu
  • E. ÖzcelikEmail author
  • O. Ucar
Original Article

Abstract

Background

Ozone therapy is employed as a therapeutic agent in various diseases. Since ozone itself is a radical, using a small dosage of it is known to create an oxidative preconditioning in the body and trigger a strong antioxidant response against that. Coenzyme Q10, as a strong antioxidant agent, is delivered as a supportive factor in many diseases involving oxidative stress.

Aim

The aim of the study was to evaluate the effects of the combination treatment over oxidative stress in healthy individuals.

Methods

In the current study, 11 healthy volunteers were administered a combination of ozone therapy and Q10 for 1 month. Blood samples were collected first right after the initial ozone therapy and then 1 month after the ozone therapy + coenzyme Q10 treatment. We measured erythrocyte superoxide dismutase and catalase enzyme activities along with serum malondialdehyde levels.

Results

Compared with the pretreatment values, an increase was determined in the erythrocyte superoxide dismutase and catalase enzyme activities. However, malondialdehyde, an indicator of oxidative membrane damage, showed a reduction after the combination treatment.

Conclusion

The results of this study reveal the beneficial effects of ozone therapy + coenzyme Q10 combination in prevention of oxidative damage.

Keywords

Coenzyme Q10 Malondialdehyde Ozone therapy Oxidative stress Superoxide dismutase 

Notes

Acknowledgments

We thank Maya Sante Medical Center (Eskisehir) and its staff for providing samples from healthy subjects subjected to ozone therapy and Co Q10.

Conflict of interest

None declared.

References

  1. 1.
    Merin O, Attias E, Elstein D et al (2007) Ozone administration reduces reperfusion injury in an isolated rat heart model. J Card Surg 22:339–342PubMedCrossRefGoogle Scholar
  2. 2.
    Hernandez FA, Calunga JL, Turrent J, Mene′ndez Cepero S, Montenegro Perdomo A (2005) Ozone therapy effects on biomarkers and lung function in asthma. Arch Med Res 36:549–554CrossRefGoogle Scholar
  3. 3.
    Chen H, Xing B, Liu X et al (2008) Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury. Eur J Pharmacol 10:306–314CrossRefGoogle Scholar
  4. 4.
    Eliakim R, Karmeli F, Rachmilewitz D, Cohen P, Zimran A (2001) Ozone enema: a model of microscopic colitis in rats. Dig Dis Sci 46:2515–2520PubMedCrossRefGoogle Scholar
  5. 5.
    Bocci V (2007) The case for oxygen-ozonetherapy. Br J Biomed Sci 64(1):44–49PubMedGoogle Scholar
  6. 6.
    Hernández FA (2007) To what extent does ozone therapy need a real biochemical control system? Assessment and importance of oxidative stress. Arch Med Res 38:571–578PubMedCrossRefGoogle Scholar
  7. 7.
    Madej P, Plewka A, Madej JA et al (2007) Ozonotherapy in an induced septic shock. I. Effect of ozonotherapy on rat organs inevaluation of free radical reactions and selected enzymatic systems. Inflammation 30:52–58PubMedCrossRefGoogle Scholar
  8. 8.
    Ajamieh HH, Berlanga J, Merino N et al (2005) Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion. Transpl Int 18:604–612PubMedCrossRefGoogle Scholar
  9. 9.
    Méndez-Alvarez E, Soto-Otero R, Sánchez-Sellero I, López-Rivadulla LM (1998) In vitro inhibition of catalase activity by cigarette smoke: relevance for oxidative stress. J Appl Toxicol 18:443–448PubMedCrossRefGoogle Scholar
  10. 10.
    Xing HB, Liu X, Zhan B, Zhou J, Zhu H, Chen Z (2008) Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Chen Arch Med Res 39:169–178Google Scholar
  11. 11.
    Tsuneki H, Sekizaki N, Suzuki T et al (2007) Coenzyme Q10 prevents high glucose-induced oxidative stress in human umbilical vein endothelial cells. Eur J Pharmacol 566:1–10PubMedCrossRefGoogle Scholar
  12. 12.
    Cooke M, Iosia M, Buford T et al (2008) Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals. J Int Soc Sports Nutr 4:5–8Google Scholar
  13. 13.
    Winterborn CC, Hawkins RE, Brain M et al (1975) The estimation of red cell superoxide dismutase activity. J Lab Clin Med 85:337–341Google Scholar
  14. 14.
    Beutler E (1982) Catalase. Manual of biochemical method. Grune and Stratton, New York, pp 105–106Google Scholar
  15. 15.
    Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMedCrossRefGoogle Scholar
  16. 16.
    Devesa E, Menendez S, Rodrõguez MM, Gome ZM, Garcõa J (1993) Ozone therapy in ischemic cerebrovascular disease. In: Proceedings of 11th ozone world congress (USA) Ozonein Medicine M-4–10 to M-4–18Google Scholar
  17. 17.
    Romero A, Menendez S, Gomez M, Ley J (1993) Ozone therapy in the advanced stages of arteriosclerosis obliterans. Angiologõa 45:146–148Google Scholar
  18. 18.
    Menendez S, Iglesias O, Bidot C, Puga R, Carballo A (1995) Application of ozone therapy in children with humoral immunity deficiency. In: International Ozone Association (ed) Proceedings of 12th ozone world congress, ozone in medicine. Lille, pp 271–274Google Scholar
  19. 19.
    Bocci V (1996) Ozone as a bioregulator pharmacology and toxicology of ozone therapy today. J Bil Regulat Homeost Agent 10:31–53Google Scholar
  20. 20.
    León OS, Menéndez S, Merino N et al (1998) Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm 7:289–294PubMedCrossRefGoogle Scholar
  21. 21.
    Zamora ZB, Borrego A, López OY et al (2005) Effects of ozone oxidative preconditioning on TNF-alpha release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock. Mediators Inflamm 24:16–22CrossRefGoogle Scholar
  22. 22.
    Al-Dalain SM, Martínez G, Candelario-Jalil E et al (2001) Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol Res 44:391–396PubMedCrossRefGoogle Scholar
  23. 23.
    González R, Borrego A, Zamora Z et al (2004) Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats. Mediators Inflamm 13:307–312PubMedCrossRefGoogle Scholar
  24. 24.
    Ajamieh HH, Menéndez S, Martínez-Sánchez G et al (2004) Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia–reperfusion. Liver Int 24:55–62PubMedCrossRefGoogle Scholar
  25. 25.
    Calunga JL, Zamora ZB, Borrego A et al (2005) Ozone therapy on rats submitted to subtotal nephrectomy: role of antioxidant system. Mediators Inflamm 31:221–227CrossRefGoogle Scholar
  26. 26.
    Bentinger M, Brismar K, Dallner G (2007) The antioxidant role of coenzyme Q. Mitochondrion 7:41–50CrossRefGoogle Scholar
  27. 27.
    Kwong LK, Kamzalov S, Rebrin I et al (2002) Effects of coenzyme Q(10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic Biol Med 33:627–638PubMedCrossRefGoogle Scholar
  28. 28.
    Tiano L, Belardinelli R, Carnevali P, Principi F, Seddaiu G, Littarru GP (2007) Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 28:2249–2255PubMedCrossRefGoogle Scholar
  29. 29.
    Groneberg DA, Kindermann B, Althammer M et al (2005) Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Int J Biochem Cell Biol 37:1208–1218PubMedCrossRefGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2011

Authors and Affiliations

  • M. İnal
    • 1
  • A. Dokumacioglu
    • 1
  • E. Özcelik
    • 1
    Email author
  • O. Ucar
    • 2
  1. 1.Department of Biochemistry, Medicine FacultyOsmangazi UniversityMeselik, EskisehirTurkey
  2. 2.Maya Sante Medical CenterEskisehirTurkey

Personalised recommendations